002737.SZ
葵花药业
SZSE · Healthcare · C 制造业 · CN
CNY 12.86
−1.38%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−72.7x
Market Cap
CNY 7.51B
MomentumView details →
1D Return
−1.38%
YTD Return
−19.91%
RSI (14)
32.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−72.7x
Market Cap
CNY 7.51B
RSI (14)
32.2
MomentumView details →
1D Return
−1.38%
YTD Return
−19.91%
Similar companies
Latest newsMore news →
Kuihua Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 79.4695 million yuan, down 2.26% year-on-year, with revenue of 1.498 billion yuan, up 14.34%.7d agoSunflower Pharmaceutical's controlling subsidiary Sunflower Pharmaceutical Group (Hengshui) Defier Co., Ltd. received a drug registration certificate from the National Medical Products Administration for glucosamine sulfate capsules, enriching the company's rheumatism and bone disease product pipeline.14d ago